A phase I/II, open label, multi-centre study to assess the safety, tolerability, and efficacy of MG010 in combination with sorafenib in subjects with solid tumours who have failed existing treatments.
ACTRN 12620000849998 Brief Summary This purpose of this study is to determine…
Read more arrow_forward